首页> 外文期刊>Bulletin of the Korean Chemical Society >Peripheral Inhibition of Small C-Termlnal Domain Phosphatase 1 With Napthoqnlnone Analogs
【24h】

Peripheral Inhibition of Small C-Termlnal Domain Phosphatase 1 With Napthoqnlnone Analogs

机译:用萘铵酮类似物的小C冠状域磷酸酶1的外周抑制

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Small C-terminal domain phosphatase 1(SCP1)'s biological function is significant in many cellular activities. Still, a recent study on neuroglioma cells emphasized the requirement of negative regulation of SCP1 in cancer Invasion suppression. Due to the structural conservation of C-terminal domain (CTD) phosphatases, we aimed to determine the peripherally targeting inhibitors, which reciprocally bind to an eccentric site on SCP1 using a multidisciplinary approach. From biochemical screening, we have identified two potential inhibitors, which showed twofold to threefold selectivity toward SCP1 compared to Dullard. Dullard was utilized as a negative control as it is a small CTD phosphatase that contains structural similarities to SCP1. Besides, from in silico approaches like protein-ligand docking and molecular dynamics analyses, we have successfully discovered two allosteric Inhibitors of napthoquinone family compounds explicitly binding to the unique hydrophobic pocket of SCP1 from 1000 molecular dockings and 125 ns of dynamics simulation studies, respectively.
机译:小C末端域磷酸酶1(SCP1)的生物功能在许多细胞活性中显着。尽管如此,最近关于神经胶瘤细胞的研究强调了对癌症入侵抑制中SCP1的负调节的要求。由于C-末端结构域(CTD)磷酸酶的结构保护,我们旨在确定外围靶向抑制剂,其使用多学科方法互相结合SCP1上的偏心部位。从生物化学筛查中,我们已经确定了两个潜在的抑制剂,其与毫无杜拉德相比,对SCP1的三重选择性显示出两倍。静音用作阴性对照,因为它是含有与SCP1结构相似性的小CTD磷酸酶。此外,从蛋白质 - 配体对接和分子动力学分析等硅方法中,我们已经成功发现了腹腔醌类的两种变构抑制剂,分别从1000分子解码和125ns的动力学模拟研究中明确结合到SCP1的独特疏水口袋。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号